Donor safety in triple plateletpheresis: Results from the German and Austrian Plateletpheresis Study Group multicenter trial

Transfusion

Volumn 53, Issue 1, 2013, Pages 211-220

  Heuft, Hans Gert ^a   Moog, Rainer ^b   Fischer, Eike G ^b   Zingsem, Jürgen ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD DONOR; BLOOD TOXICITY; BLOOD TRANSFUSION REACTION; CITRATE TOXICITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MULTICENTER STUDY; NORMAL HUMAN; PATIENT SAFETY; PRODUCT SAFETY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS; TREATMENT WITHDRAWAL; VASCULAR ACCESS;

ADULT; AUSTRIA; BLOOD DONORS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PLATELETPHERESIS;

EID: 84872272607     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03714.x     Document Type: Article

References (24)

1. Valbonesi AM, Florio G, Venturino V, Bruni R,. Plateletpheresis: what's new? Transfus Sci 1996; 17: 537-44.
2. Murphy MF, Seghatchian J, Krailadsiri P, Howell C, Verjee S,. Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion. Transfus Sci 2000; 22: 39-43.
3. Moog R, Zeiler T, Heuft HG, Stephan B, Fischer EG, Kretschmer V, Rodel-Spiecker R, Strasser E, Zingsem J,. Collection of WBC-reduced single-donor PLT concentrates with a new blood cell separator: results of a multicenter study. Transfusion 2003; 43: 1107-14.
4. Ringwald J, Zingsem J, Zimmermann R, Strasser E, Antoon M, Eckstein R,. First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors. Vox Sang 2003; 85: 267-75.
5. Zingsem J,. Multicomponent apheresis. ISBT Sci Ser 2010; 5: 83-7.
6. Picker SM, Radojska SM, Gathof BS,. Evaluation of concurrent collection of in-line filtered platelets and packed red blood cells by multicomponent apheresis with three last-generation apparatuses. Vox Sang 2006; 91: 47-55.
7. Strauss RG,. Risks of clinically significant thrombocytopenia and/or lymphocytopenia in donors after multiple plateletpheresis collections. Transfusion 2008; 48: 1274-8.
8. Lazarus EF, Browning J, Norman J, Oblitas J, Leitman SF,. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 2001; 41: 756-61.
9. Fontana S, Mordasini L, Keller P, Taleghani BM,. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators. Transfusion 2006; 46: 2004-10.
10. Picker SM, Radojska SM, Gathof BS,. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 2006; 46: 1601-8.
11. Richa E, Krueger P, Burgstaler E, Bryant S, Winters J,. The effect of double and triple apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion 2008; 48: 1325-32.
12. Katz L, Palmer K, McDonnell E, Kabat A,. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors. Transfusion 2007; 47: 1601-6.
13. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 12th ed. Strasbourg: Council of Europe; 2006. p. 48.
14. German Medical Association and the Paul-Ehrlich-Institute. Guidelines for the collection of blood and blood components and to the usage of blood products. Köln, Germany: Deutscher Ärzte-Verlag; 2010. p. 26-7f.
15. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S,. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-13.
16. Moog R,. Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apher 2009; 24: 238-40.
17. Heuft HG, Goudeva L, Peine S, Martens J, Schmitt-Thomssen A, Blasczyk R,. Routine collection of triple platelet components using two different apheresis systems [abstract]. Transfus Med Hemother 2005; 32: 26.
18. Heuft HG, Goudeva L, Martens J, Schmitt-Thomssen A, Blasczyk R,. The mobilization effect of platelet apheresis [abstract]. Transfus Med Hemother 2006; 33: 17.
19. Axelrod FB,. The growing practice of splitting double dose apheresis platelet products. Transfus Sci 1993; 14: 364-8.
20. Fontana S, Keller P, Mansouri Taleghani B,. Platelet recruitment during multiple donor platelet apheresis differs between cell separators. Transfus Med Hemother 2011; 38: 195-8.
21. Winters JL,. Complications of donor apheresis. J Clin Apher 2006; 21: 132-41.
22. Bueno JL, Castro E, García F, Barea L, González R,. Hematomas in multicomponent apheresis: searching for related factors. Transfusion 2006; 46: 2184-91.
23. Makar YF, Butler MO, Cockersole GM, Gabra G, Serevitch JM,. National audit of citrate toxicity in plateletpheresis donors. Transfus Med 2002; 12: 187-91.
24. McLeod BC, Price TH, Owen H, Ciavarella D, Sniecinski I, Randels MJ, Smith JW,. Frequency of immediate adverse effects associated with apheresis donation. Transfusion 1998; 38: 938-43.